Cargando…
Cost Effectiveness of a Shorter Moxifloxacin Based Regimen for Treating Drug Sensitive Tuberculosis in India
Globally efforts are underway to shorten the existing 6-month tuberculosis (TB) treatment regimen for drug-sensitive patients, which would be equally effective and safe. At present, there is a lack of evidence on the cost implications of a shorter 4-month TB regimen in India. This economic modeling...
Autores principales: | Muniyandi, Malaisamy, Karikalan, Nagarajan, Velayutham, Banurekha, Rajsekar, Kavitha, Padmapriyadarsini, Chandrasekaran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9607110/ https://www.ncbi.nlm.nih.gov/pubmed/36288029 http://dx.doi.org/10.3390/tropicalmed7100288 |
Ejemplares similares
-
A national-level analysis of life expectancy associated with the COVID-19 pandemic in India
por: Muniyandi, Malaisamy, et al.
Publicado: (2022) -
An influence of dew point temperature on the occurrence of Mycobacterium tuberculosis disease in Chennai, India
por: Krishnan, Rajendran, et al.
Publicado: (2022) -
An economic evaluation of implementing a decentralized dengue screening intervention under the National Vector Borne Disease Control Programme in Tamil Nadu, South India
por: Muniyandi, Malaisamy, et al.
Publicado: (2021) -
Estimating TB diagnostic costs incurred under the National Tuberculosis Elimination Programme: a costing study from Tamil Nadu, South India
por: Muniyandi, Malaisamy, et al.
Publicado: (2021) -
The Cost-Effectiveness of the BEAT-TB Regimen for Pre-Extensively Drug-Resistant TB
por: Muniyandi, Malaisamy, et al.
Publicado: (2023)